The same divergence flagged three days ago has intensified. HTZ now has essentially no shares left to borrow, cost to borrow has nearly doubled again since the last note, and options traders have pushed to their most bullish reading in a full year — even as the stock sits 48% lower than it did a month ago.
These signals are pulling in opposite directions. The lending market screams maximum short pressure. Options traders are positioned for a reversal.
Availability stands at 0.62%. That means roughly one share remains available to borrow for every 160 already lent out. The lending pool is, for practical purposes, closed.
Cost to borrow hit 7.03% as of June 26. One week ago it was 1.19%. That is a 489% move in five sessions. For most of June, CTB sat between 1.1% and 1.6%. The repricing that began on June 25 — when CTB first broke above 3.5% — has continued to accelerate. Borrowing HTZ shares now costs nearly six times what it cost two weeks ago.
Short interest is 20.3% of free float, up 12.7% in a week. The ORTEX short score sits at 74.1, in the 4th percentile among all tracked names — meaning 96% of stocks carry less short pressure than HTZ.
The put-call ratio fell to 1.42 on June 26. That is the lowest reading in 52 weeks. The 20-day mean is 2.08. The current level sits 2.5 standard deviations below that mean.
For the past month, PCR had been anchored between 2.18 and 2.31. The drop began on June 22 and has accelerated every session since. Options positioning has rotated from persistently bearish to the most bullish extreme of the past year — all while the stock was cratering.
Call buyers paying up into a 48% drawdown, against a frozen borrow market, is an unusual configuration.
The insider picture adds a third layer. The CFO sold 149,961 shares at $4.83 on June 17. The COO sold 140,822 shares at $5.13 on June 12. The CEO sold 250,577 shares at $5.18 in early April. All three executives were reducing at prices well above where the stock trades today ($2.64). Net insider selling over the past 90 days totals approximately $3 million in value.
The next earnings event is scheduled for August 6.
See the live data behind this article on ORTEX.
Open HTZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
